High-Dose Radioiodine Therapy Did Not Result in Better Thyroglobulin Decline in Patients with Extra-Thyroid Tumor Extension of Papillary Thyroid Cancer
The administration of higher radioiodine doses for the treatment of PTC patients with ETE does not yield additional therapeutic benefits in terms of posttreatment thyroglobulin reduction.
Authors
- Yalda Salehi (ORCID: https://orcid.org/0000-0002-2725-7880)
- Mohamad Ghazanfari Hashemi
- Mohsen Bakhshi Kashi
- Saeed Farzanefar
- Mehrshad Abbasi (ORCID: https://orcid.org/0000-0001-5011-897X)
- Mohammad Reza Ghasri
Institutions
- University of Tehran (IR)
- Imam Khomeini Hospital (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- World Journal of Nuclear Medicine
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1055/s-0045-1802954
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00